Additional quality assessments evaluate physicochemical characteristics relevant to laboratory use, including solubility, molecular integrity, and stability under recommended storage conditions
Preclinical research has demonstrated cytoprotective properties across multiple organ systems, including the gastrointestinal tract, liver, pancreas, heart, and nervous system
Contact support for documentation
In the absence of medicinal claims to treat or cure an adverse medical condition, vitamin injections are not necessarily medicinal products and MHRA reviews products on a case-by-case basis to determine if they are caught by the definition of a medicinal product in the relevant legislation
It is also used to treat pernicious anemia, vitamin B 12 deficiency (due to low intake from food or inability to absorb due to genetic or other factors), thyrotoxicosis, hemorrhage, malignancy, liver disease and kidney disease